Royal Bank of Canada’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Royal Bank of Canada’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-28,922	Closed	-$295K	–	7886
2023 Q3	$295K	Buy	28,922 +1,259	+5%	+$9.59K	﹤0.01%	4468
2023 Q2	$130K	Buy	27,663 +1,085	+4%	+$4.99K	﹤0.01%	5119
2023 Q1	$123K	Buy	26,578 +21,123	+387%	+$93K	﹤0.01%	5019
2022 Q4	$20K	Buy	5,455 +2,188	+67%	+$9.7K	﹤0.01%	6310
2022 Q3	$16K	Buy	3,267 +3,089	+1,735%	+$15.5K	﹤0.01%	6244
2022 Q2	$0	Sell	178 -335	-65%	-$2.04K	﹤0.01%	7924
2022 Q1	$4K	Sell	513 -894	-64%	-$4.81K	﹤0.01%	7354
2021 Q4	$9K	Buy	+1,407	New	+$11K	﹤0.01%	7092

Royal Bank of Canada's THRN Position: Q4 2023 in Review

Royal Bank of Canada sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 28,922 shares — an estimated $295K sold.

Royal Bank of Canada first reported a position in THRN in Q4 2021 and held it in 8 quarters. The position peaked at $295K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

Royal Bank of Canada reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Royal Bank of Canada sold 28,922 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $295K.
Royal Bank of Canada first reported a position in Thorne Healthtech, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Royal Bank of Canada's Thorne Healthtech, Inc. Common Stock position peaked at $295K in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.